ExeVir

0 followers


Rapid viral control in a world that needs it. ExeVir develops single-domain antibody-based therapies that help patients ward off viral infections. Our lead drug candidate is in accelerated development as a COVID-19 therapeutic.

Industries

+1

Headquarters

Employees

Links

Org chart

Torsten Mummenbrauer

Collapse
Xavier Saelens
Scientific Founder & Research Collaborator
Nico Callewaert
Scientific Founder & Research Collaborator
Antoine THOMAS
Head of External Manufacturing
Viki Bockstal
Chief Scientific Officer